Keywords: تموزولاماید; CSC; cancer stem cells; EMT; epithelial to mesenchymal transition; MET; mesenchymal to epithelial transition; AML; acute myeloid leukemia; ALDH1; aldehyde dehydrogenase 1; BCSC; breast cancer stem cell; Lgr5; G-protein-coupled receptor 5; GSC; glioblastom
مقالات ISI تموزولاماید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تموزولاماید; 5-Aza; 5-Aza-2-deoxycytidine; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; BIR; baculoviral inhibitor of apoptosis repeat; CAD; caspase-activated deoxyribonuclease; CDK; cyclin-dependent kinase; cIAP; cellular inhibitor of apoptosis; CL
Keywords: تموزولاماید; Anti-PD1 receptor; BRAF 600E mutation; Melanoma; Pembrolizumab; Primary solitary cerebral malignant melanoma; Primary solitary intracranial malignant melanoma; CT; Computed tomography; GTR; Gross total removal; IQR; Interquartile range; MMM; Metastatic ma
Keywords: تموزولاماید; Glioblastoma; Meta-analysis; Recurrence; Repeat surgery; Systematic review; CI; Confidence interval; EC; Effect coefficient; GBM; Glioblastoma; HR; Hazard ratio; OS; Overall survival; QoL; Quality of life; TMZ; Temozolomide;
Keywords: تموزولاماید; blood-brain barrier; chronic ischemic stroke; mannitol; mesenchymal stromal cell; temozolomide; umbilical cord;
Keywords: تموزولاماید; Brain neoplasm; Clinical trials; Glioblastoma; Immunotherapeutic; Immunotherapy; Vaccine; APC; Antigen-presenting cell; APVAC; Actively personalized vaccination; BBB; Blood-brain barrier; CMV; Cytomegalovirus; CNS; Central nervous system; CSF; Cerebrosp
Keywords: تموزولاماید; Astrocytoma; Oligodendroglioma; Anaplastic; IDH; 1p/19q codeletion; PCV; Temozolomide; Bevacizumab;
Keywords: تموزولاماید; Polytherapy; Targeting; Doxorubicin; Temozolomide; Polysaccharides; Folic acid; chitosan (PubChem CID: 71853); alginic acid sodium salt (PubChem CID: 5102882); folic acid (PubChem CID: 6037); doxorubicin hydrochloride (PubChem CID: 443939); temozolomide (
Keywords: تموزولاماید; Anticancer activity; Apoptosis; DNA repair; Glioblastoma; Seaweed compounds; Temozolomide; AIC; 5-aminoimidazole-4-carboxamide; Akt; Protein kinase B (PKB); AP site; apurinic/apyrimidinic site; AP-1; activator protein-1; APE-1; AP endonuclease; Bax; Bcl-2
Keywords: تموزولاماید; ACSVL3; acyl-coA synthetase VL3; ALDH1; aldehyde dehydrogenase; ALDOA; aldolase A; ALDOC; aldolase C; AMPK; 5â² AMP-activated protein kinase; ASNS; asparagine synthetase; BTICs; brain tumor initiating cells; 3-BrOP; 3-bromo-2-oxopropionate-1-propyl ester
Keywords: تموزولاماید; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ADAM; a disintegrin and metalloproteinase enzymes; ALDH; aldehyde dehydrogenase; ABC; ATP - binding cassette; BWS; Beckwith-Wiedemann syndrome; BMP; bone morphogenetic proteins; CSC; cancer s
Keywords: تموزولاماید; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Temozolomide; Glioblastoma; Semi-quantitative reverse transcription-PCR;
Keywords: تموزولاماید; GBM; glioblastoma multiforme; TMZ; temozolomide; MGMT; O6 methylguanine- DNA methyltransferase; HDAC; histone deacetylase; HDACI; HDAC inhibitor; HMG-CoA; 3-hydroxy-3-methylglutaryl-CoA; VPA; valproic acid; ROS; reactive oxygen species; NaB; sodium butyra
Keywords: تموزولاماید; EORTC; European Organisation for Research and Treatment of Cancer; FDA; Food and Drug Administration; GBM; glioblastoma multiforme; GFR; growth factor receptor; IDH; isocitrate dehydrogenase gene; KPS; Karnofsky Performance Status; MGMT; O6-methylguanine-
Keywords: تموزولاماید; Recurrent malignant glioma; ATRX; Alpha thalassemia/mental retardation syndrome X-linked; Bev; Bevacizumab; CNS; Central nervous system; EGFR; Epidermal growth factor receptor; GBM; Glioblastoma multiforme; Gy; Gray; HRQoL; Health-related quality of life;
Keywords: تموزولاماید; Glioblastoma; Temozolomide; Therapeutic resistance; Molecular mechanisms; Therapeutic advances;
Keywords: تموزولاماید; Chemotherapy; Health-related quality of life; High-grade glioma; KPS; Recurrence therapy; Recurrent surgery; Re-radiation; Bev; Bevacizumab; CCNU; Lomustine; EORTC QLQ-BN20; European Organisation for Research and Treatment of Cancer Quality of Life Questi
Keywords: تموزولاماید; Biomarkers; Checkpoint molecules; Cytokines; Glioblastoma; Immunotherapy; Microbiome; Mutational landscape; CB; Cintredekin besudotox; CNS; Central nervous system; CTLA-4; Cytotoxic T lymphocyte antigen 4; CyTOF; Cytometry by time-of-flight; EGFR; Epiderm
Keywords: تموزولاماید; Glioblastoma; Elderly; Geriatric assessment; Temozolomide; MGMT;
Keywords: تموزولاماید; HR; hazard ratio; CI; confidence interval; MRI; Magnetic Resonance Imaging; OS; overall survival; PFS; progression-free survival; RPA; recursive partitioning analysis; RTOG; Radiation Therapy Oncology Group; WHO; World Health Organization; Glioblastoma; S
Keywords: تموزولاماید; Chemotherapy; Lomustine and vincristine; Low grade glioma; Procarbazine; Radiotherapy; Temozolomide
Keywords: تموزولاماید; GBM; glioblastoma; TMZ; temozolomide; CPD; Cumulative Population Doubling; RTCT; Relative Time to Cross a Threshold; rAUC; relative Area Under Curve; RPR; Relative Proliferation Rate; RendCPD; Relative end CPD; Temozolomide; Glioblastoma; Cumulative popul
Keywords: تموزولاماید; Glioblastoma; Lipid droplets; Curcumin; Pyrrolidine-2; Caspase-3 sensor; Cell death; Sensitization; Temozolomide; Spheroids; Chemotherapy;
Keywords: تموزولاماید; Pancreatic neuroendocrine tumor; Somatostatin analogue; mTOR; Everolimus; Sunitinib; Temozolomide;
Keywords: تموزولاماید; Cytostatic agents; Emerging contaminants; Environmental samples; Liquid chromatography; Gas chromatography; 5-FU; 5-Fluorouracil; ACT-D; actinomycin-D; A-GLU; Aminoglutethimide; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure ph
Keywords: تموزولاماید; ACPP; activated cell-penetrating peptide; AFM; atomic force microscopy; AN; angiopeptin; ANP; NP modified with ACPP peptide; APE-1; apurinic endonuclease-1; AU; gold; AUC; area under the curve; AUNP; gold nanoparticles; AUNS; gold nanoshells; BAT; brain a
Keywords: تموزولاماید; Glioblastoma; MGMT; Temozolomide; Nitrosourea; Bevacizumab; Immunotherapy;
Keywords: تموزولاماید; 1p19q; Anaplastic gliomas; IDH1; MGMT; Prognosis; Recurrence; Temozolomide
Keywords: تموزولاماید; Gamma Knife radiosurgery; Glioblastoma; Recurrent; Salvage treatment; Temozolomide
Keywords: تموزولاماید; Glioblastoma; Cancer; High grade glioma; Incidence; Treatment; Elderly; Paediatric; Outcome; Population studies; Temozolomide;
Keywords: تموزولاماید; Glioblastoma; Treatment; Review; Pharmacology; Targeted therapy; Stem cell; AKT; protein kinase B; BBB; blood-brain barrier; BCNU; carmustin; CCNU; lomustin; c-MET; hepatocyte growth factor receptor; EGF(R); epidermal growth factor (receptor); EGFRvIII; e
Keywords: تموزولاماید; AAV; adeno-associated virus; BBB; blood-brain barrier; BBBD; blood-brain barrier disruption; BCNU; bis-chloroethylnitrosourea or carmustine; BNCT; boron neutron capture therapy; BPN; brain-penetrating nanoparticle; CNS; central nervous system; DOX; do
Keywords: تموزولاماید; Adjuvant; Cancer; Giant cell glioblastoma; Recurrence; Resection; Survival; Temozolomide
Keywords: تموزولاماید; 5-ALA; 5-amino-levulinic acid; RGD; arginine-glycine-aspartic acid; BBB; blood-brain barrier; BCNU; carmustine; CASANT; carmustine sustained-release implant; CNS; central nervous system; CED; convection-enhanced delivery; c(RGDyK); cyclic arginineâ
Keywords: تموزولاماید; VEGF(R); vascular endothelial growth factor (receptor); EGF(R); epidermal growth factor (receptor); LGG; low-grade glioma; HGG; high-grade glioma; DIPG; diffuse intrinsic pontine glioma; PDGF(R); platelet derived growth factor (receptor); P(I)GF; placenta
Keywords: تموزولاماید; ÎKG; α-ketoglutarate; AML; acute myeloid leukemia; BCAT1; branched-chain amino acid transporter 1; BRD4; bromodomain-containing protein 4; D-2HG; D-2-hydroxyglutarate or R-2-hydroxyglutarate; D-2HGA; D-2-hydroxyglutarate aciduria; D2HGDH; D-2-hydroxyglu
Keywords: تموزولاماید; Elderly; Glioblastoma; Radiotherapy; Temozolomide; Survival;
Keywords: تموزولاماید; AML; acute myeloid leukemia; CAM-DR; cell adhesion-mediated drug resistance; CCP; charge-conversion polymer; CLL; chronic lymphocytic leukemia; CNS; central nervous system; CSC; cancer stem cell; EGFR; epidermal growth factor receptor; EPR; enhanced perme
Keywords: تموزولاماید; siRNA; small interfering RNA; AON; antisense oligonucleotides; shRNA; small hairpin RNA; pDNA; plasmid DNA; CYP3A; cytochrome P450 3A; MDR; multidrug resistance; MDR1; multidrug resistance protein 1; Pgp; P-glycoprotein; TRAIL; tumor necrosis factor-relat
Keywords: تموزولاماید; Glioblastoma; Malignant gliomas; MGMT; Temozolomide; Elderly; Radiotherapy; Cognitive dysfunction
Keywords: تموزولاماید; High-grade astrocytoma; Brain radiotherapy; Temozolomide; Recurrence patterns; Planning target volume;
Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model
Keywords: تموزولاماید; Glioma; Temozolomide; PD-1 Antibody; Chemotherapy; Immunotherapy;
Administration précoce de témozolomide après chirurgie chez des patients ayant un glioblastome de mauvais pronostic : étude de faisabilité
Keywords: تموزولاماید; Témozolomide; Glioblastome; Traitement adjuvant précoce; Toxicité; Temozolomide; Glioblastoma; Early adjuvant treatment; Toxicity;
Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model
Keywords: تموزولاماید; Pleomorphic liposarcoma; PDOX; Pazopanib; PDGFRA; Targeted therapy; Temozolomide;
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
Keywords: تموزولاماید; ALECSAT; Autologous Lymphoid Effector Cells Specific Against Tumor Cells; CTA; Cancer/testis antigens; CSC; Cancer stem cells; CTL; Cytotoxic T lymphocytes; FBS; Fetal bovine serum; GBM; Glioblastoma; HGG; High-grade glioma; MHC; Major histocompatibility
Value of 18F-FET PET in adult brainstem glioma
Keywords: تموزولاماید; ADC; apparent diffusion coefficient; BSG; brain stem glioma; Cho; choline; CT; computed tomography; DTI; diffusion tensor imaging; DWI; diffusion weighted imaging; FET; 18F-fluoro-ethyl-tyrosine; FLAIR; fluid-attenuated inversion recovery; GBM; glioblasto
X-inactive-specific transcript: A long noncoding RNA with complex roles in human cancers
Keywords: تموزولاماید; AR; androgen receptor; ATG7; autophagy related 7; Bcl2; B-cell lymphoma-2; BRCA1; breast cancer-associated protein 1; CCND1; cyclin D1; CDK4/6; cyclin dependent kinase 4/6; CDX1; caudal type homeobox 1; CRC; colorectal cancer; EMT; epithelial mesenchymal
Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
Keywords: تموزولاماید; 18F-FDOPA; 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine; 18F-FLT; [18F]-fluoro-3-deoxy-3-L-fluorothymidine; ADC; apparent diffusion coefficient; AVOL; arterio-venous overlap; BBB; blood brain barrier; CBF; cerebral blood flow; CBV; cerebral blood volume;
From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo
Keywords: تموزولاماید; Medroxyprogesterone; Progesterone analogues; Dexamethasone; Temozolomide; Glioblastoma;
Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway
Keywords: تموزولاماید; Malignant glioma; Honokiol; Temozolomide; Apoptosis; Intrinsic pathway; ANOVA; analysis of variance; Bax; Bcl-2-associated X protein; BrdU; bromodeoxyuridine; CI; combination index; DEVD; Asp-Glu-Val-Asp; DiOC6; 3,3â²-dihexyloxacarbocyanine; DAPI; 4â²-6